Categories AlphaGraphs, Earnings

CarMax stock rises on upbeat results

CarMax (KMX) reported a 12.7% increase in earnings for the first quarter helped by the lower effective tax rate. The used vehicle retailer’s shares rose about 10% in the premarket after its revenue and earnings came in above the Street’s expectations. With sales rising 5.5% to $4.79 billion, earnings stood at $238.7 million and EPS climbed 17.7% to $1.33.

CarMax’s bottom line turned profitable despite incurring an increase in costs and expenses, thanks to the 2017 tax act. The company’s stores faced lesser traffic that can be seen from a 2.3% decline in comparable store sales. But, with the help of pricing, total used vehicle unit sales rose 1.6%.

Total wholesale vehicle unit sales increased 9.6%, largely driven by an increase in its appraisal buy rate and the growth in store base. Other sales and revenues increased by 5.7% compared with a year ago.

CarMax Q1 2019 Earnings Infographic
CarMax Q1 2019 Earnings Infographic

During the recently ended quarter, the Richmond, Virginia-based company opened two stores in existing television markets (Dallas and Miami) and entered the Greenville, North Carolina television market. Following the end of the quarter, CarMax opened a store in Santa Fe, New Mexico. The company plans to open 15 new stores before May 31, 2019.

For fiscal 2019, the company plans to enter ten new television markets and expand its presence in five existing television markets. Of the 15 stores CarMax plans to open during the 12 months ending May 31, 2019, nine will be in Metropolitan Statistical Areas having populations of 600,000 or less.

During the first quarter, CarMax bought back 3.3 million common shares for $207.4 million. As of May 31, 2018, the company had $809.5 million balance available for repurchase under the current authorization.

Shares of CarMax ended Thursday’s regular trading session down 2.36% at $71.05 on the NYSE. The stock had been trading between $57.05 and $77.64 for the past 52 weeks.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top